Obstetrics & Gynecology · Roseville, CA
NPI
1770661480
Since 2006
Specialty
Obstetrics & Gynecology
Code 207V00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1600 Eureka Rd
Roseville, CA, 95661
Phone (916) 784-4000
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$66K
523 prescriptions
Company payments, 2024
$18.46
From 1 companies
Medicare prescription drug claims, 2024
In 2024, the drug Kimberly M Kopecky prescribed most often to Medicare patients was Estradiol, with 138 prescriptions and refills. In total Kimberly M Kopecky wrote 523 Medicare prescriptions that cost $66K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-03.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Estradiol Generic | 138 | 579 | 93 | $5,917 |
| Estring Estradiol | 70 | 210 | 26 | $43K |
| Yuvafem Estradiol | 60 | 152 | 27 | $6,238 |
| Imiquimod Generic | 19 | 23 | Under 11 | $377 |
| Climara Estradiol | 17 | 47 | Under 11 | $2,373 |
| Acyclovir Generic | 16 | 35 | Under 11 | $324 |
| Clobetasol Propionate Generic | 15 | 15 | 12 | $253 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 13 | 43 | Under 11 | $228 |
| Trospium Chloride Generic | 12 | 37 | Under 11 | $577 |
| Progesterone Progesterone, Micronized | 12 | 40 | Under 11 | $551 |
| Norethindrone Acetate Generic | 11 | 24 | Under 11 | $492 |
Brand drugs: 94 claims; generic drugs: 429 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Kimberly M Kopecky $18.46 ($18.46 in general payments such as food, travel and fees) from 1 company. The largest payer was Hologic Sales and Service, LLC with $18.46.
| Company | Payments | Amount |
|---|---|---|
| Hologic Sales and Service, LLC HOLX | 1 | $18.46 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.